Medical information Clinical review pending

Genetic Testing

SLC2A1 Gene DYT8 Genetic Test

The SLC2A1 Gene DYT8 NGS Genetic DNA Test identifies mutations linked to neurological disorders like Dystonia. This test uses Next-Generation Sequencing (NGS) to analyze your genetic material, providing insights for diagnosis and management. Consult your doctor to see if this test is right for you.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube). Confirm with the laboratory before booking.
Results: Confirm with the laboratory before booking.
Preparation: No specific fasting is required. Please consult with your doctor or the laboratory for any specific instructions. A clinical history assessment and genetic counseling session are recommended before the test.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the SLC2A1 Gene DYT8 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Family history of DYT8 dystonia or related neurological disorders.
✓Presence of symptoms suggestive of dystonia (e.g., involuntary muscle contractions, abnormal postures).
✓Consultation with a neurologist or genetic counselor regarding potential genetic causes of neurological symptoms.
✓Assessing genetic risk for specific neurological conditions.
✓Guiding treatment and management decisions based on genetic findings.

In plain language

What this test helps you understand

This test helps identify genetic mutations associated with neurological disorders, aiding in diagnosis, risk assessment, and potentially guiding management strategies for individuals with relevant symptoms or family history.

The SLC2A1 Gene DYT8 NGS Genetic DNA Test is a genetic test designed to identify mutations in the SLC2A1 gene. Mutations in this gene are associated with certain neurological disorders, including DYT8 dystonia. This test utilizes Next-Generation Sequencing (NGS) technology for a detailed analysis of the genetic material. Understanding your genetic makeup can be important for managing neurological conditions. This test specifically looks for mutations in the SLC2A1 gene that may increase the risk of developing specific neurological disorders. By analyzing your genetic code, healthcare providers can better assess risk and potentially tailor management plans. Results from this test provide insights into your genetic predisposition. A genetic counselor can help interpret these results and discuss their implications. It's important to remember that a positive result indicates an increased risk, not a certainty of developing a disorder.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific fasting is required. Please consult with your doctor or the laboratory for any specific instructions. A clinical history assessment and genetic counseling session are recommended before the test.

SampleBlood sample (EDTA tube). Confirm with the laboratory before booking.

MethodologyNext-Generation Sequencing (NGS) of the SLC2A1 gene.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test only analyzes the SLC2A1 gene. It does not detect mutations in other genes associated with neurological disorders. A negative result does not completely rule out a genetic cause for symptoms. Interpretation of results requires clinical correlation and genetic counseling.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

The SLC2A1 gene provides instructions for making a protein involved in transporting glucose across cell membranes. Mutations in this gene are linked to certain neurological disorders.

DYT8 dystonia is a type of early-onset dystonia, a movement disorder characterized by involuntary muscle contractions, often linked to mutations in the SLC2A1 gene.

Individuals with symptoms of dystonia or a family history of DYT8 dystonia or related neurological conditions should discuss this test with their doctor.

A positive result indicates the presence of a mutation in the SLC2A1 gene associated with neurological disorders. It suggests an increased risk but does not guarantee the development of the condition. Genetic counseling is recommended to interpret the results.

Results are interpreted by qualified professionals, often in conjunction with your clinical history. A genetic counselor can explain the findings and their implications for you and your family.

Yes, genetic counseling before and after testing is highly recommended to understand the test's purpose, potential results, and implications for your health and family.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp